サンプル分類1
Retatrutide
- 5mg*10vials USD 45.00
- 10mg*10vials USD 85.00
参考価格です。お支払いの前にコンシェルジュが金額を確認します。
4.2 / 5 · 3675 件注文の送信後、コンシェルジュへ連絡するときは注文番号をお知らせください。
製品の特長
Triple receptor agonist, offering the most potent fat-loss effect (24% weight reduction in clinical settings)
製品紹介
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
注意事項
Reconstitution: Add 1.0 mL of bacteriostatic water → ~ 5.0 mg/mL concentration
Typical weekly dosage range: 2–8 mg once weekly (gradually increased over 8–12 weeks)
Easy measurement: At 5.0 mg/mL, 1 unit = 0.01 mL ≈ 50 mcg (using a U-100 insulin syringe)
使い方
1. Draw 1.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam.
3. Gently swirl or roll the vial until the contents are dissolved (do not shake).
4. Label with the date and store refrigerated at 2–8°C, protected from light.
5. Use within 4 weeks of reconstitution.
保存方法
Lyophilized: Store at -20°C or lower; stable for up to 24 months.
After reconstitution: Store at 2–8°C; use within 4 weeks.
Allow the vial to reach room temperature before opening to minimize condensation.
レビュー
4.2 / 5
3675 件
最新100件を表示しています。
-
★★★★★
VXC•••••••4337
韓国
2026-10-13 20:26
The carton corner was creased. What I ordered was inside. A fair delivery overall.
-
★★★★★
VXD•••••••9F9F
韓国
2026-10-13 16:33
The box was plain and a little worn. The product matched the page. I would give the packing a pass.
-
★★★★★
VXB•••••••86FC
米国
2026-10-13 12:41
The paperwork was easy to read. The vial matched the description. Clear from start to finish.
-
★★★★★
VX8•••••••6E46
シンガポール
2026-10-13 08:48
The paperwork was easy to read. Nothing was missing. It arrived exactly as described.
-
★★★★★
VX3•••••••DCB3
その他
2026-10-13 04:55
The carton showed some wear. No pieces were missing. Support was polite, just slow.
-
★★★★★
VX8•••••••17B6
シンガポール
2026-10-13 01:03
The carton corner was creased. What I ordered was inside. The product side was correct.
-
★★★★★
VX2•••••••6A76
その他
2026-10-12 21:10
The carton corner was creased. The label matched the listing. The rest was straightforward.
-
★★★★★
VX7•••••••82D0
米国
2026-10-12 17:17
The box was plain and a little worn. Nothing was missing. Not perfect, but honest.
-
★★★★★
VXE•••••••6D96
カナダ
2026-10-12 13:24
The first delivery estimate was a bit optimistic. The contents were complete. I would give the packing a pass.
-
★★★★★
VXB•••••••CF17
韓国
2026-10-12 09:32
Arrival was calm and on schedule. The packing list was right. Glad the listing was precise.
購入者レビュー
注文時の注文番号と電話番号を入力してください。この商品を含む注文と両方が一致する必要があります。
ほかの掲載商品
サンプル分類1
Cagrilintide
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
参考価格USD 113.00
サンプル分類1
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
参考価格USD 116.00
サンプル分類1
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
参考価格USD 40.00
サンプル分類1
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
参考価格USD 41.00